Conference Reports for NATAP

AASLD 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2009 Back

Once Daily Narlaprevir (SCH 900518) in Combination with Peginterferon alfa-2b/ Ribavirin for Treatment-Naive Patients with Genotype-1 Chronic Hepatitis C: Interim Results from the NEXT-1 Study       Reported by Jules Levin AASLD Nov 2 2009, Boston, MA   Vierling J, Poordad F, Lawitz E, Ghalib R, Lee W, Ravendhran N, Galati J, Bacon B, Flamm S, Balart L, Freilich B, Schiff E, Jacobson I, Kwo P, Gordon S, Sulkowski M, Boparai N, Chaudhri E, Brass C, Hughes E, and Albrecht J